How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
U.S. CUSTOM HARVESTERS, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
H-2A reform and Non-domicile commercial driving licensing issues.
H-2A reform and Non-domicile commercial driving licensing issues.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT)
Source: Senate LDA
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
2026 · third_quarter · Q3
Tariffs on products Performance Health imports from China and other countries.
Tariffs on products Performance Health imports from China and other countries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
NATIONAL PORK PRODUCERS COUNCIL via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues concerning H-2A and TN Visa Programs.
Issues concerning H-2A and TN Visa Programs.
Issues concerning H-2A and TN Visa Programs.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL)
CURIE BIO OPERATIONS, LLC via ALSTON & BIRD LLP
2026 · third_quarter · Q3
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AUTOLIV, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues relating to the taxation of U.S. manufacturers with foreign operations.
Issues relating to tariffs and a potential new trade deal with Mexico.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
CURIE BIO OPERATIONS, LLC via ALSTON & BIRD LLP
2026 · second_quarter · Q2
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Medicare reimbursement issues.
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE